ENDPOINTS

GLP-1s may cut cancer risk; Gyre’s stock falls after hep B data and offering

2 days ago

News Briefing

Moderna pulls application for Covid-flu shot; Another IPO in Hong Kong

4 days ago

News Briefing

SV Health’s $269M dementia fund; Schrödinger lays off 7% of staff

5 days ago

News Briefing

Ionis details late-stage data for heart drug; Armata’s promising staph infection therapy

6 days ago

News Briefing

FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval

Last week

News Briefing

Enliven stops work on solid tumor drug; Pulmatrix to divest assets

Last week

News Briefing

SK, Carlyle bolster bluebird bio bid; Therini Bio raises $39M

Last week

News Briefing

Axsome's $570M loan with Blackstone; Altimmune makes its own credit deal

Last week

News Briefing

FDA clears in vivo blood stem cell editing trial; Abeona's $155M PRV sale

Last week

News Briefing

AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China

3 weeks ago

News Briefing

ALX Oncology won’t seek approval for CD47 drug in gastric cancer; Korro Bio’s layoffs

3 weeks ago

News Briefing

European regulators to review Valneva shot; Jazz's stock dips on subpar first-quarter revenue

3 weeks ago

News Briefing

Lilly to pay up to $415M in ALS deal; Actuate’s mid-stage pancreatic cancer data

3 weeks ago

News Briefing

Unity lays off 'all' workers; Novo to get FDA decision on oral Wegovy this year

3 weeks ago

News Briefing

Kura gets $45M milestone payment from Kyowa Kirin; Pliant’s restructuring

4 weeks ago

News Briefing

Arvinas ends plans for two Phase 3 breast cancer trials; Phathom makes cuts

4 weeks ago

News Briefing

Immunic’s stock falls on multiple sclerosis data; Entrada’s layoffs

4 weeks ago

News Briefing

AbbVie’s Rinvoq is approved in giant cell arteritis; Relmada shares bladder cancer data

4 weeks ago

News Briefing

Biohaven gets an up to $600M investment; Prilenia, Ferrer make a deal in Europe

4 weeks ago

News Briefing

Lilly asks EU regulator to revisit Kisunla; CHMP recommends PTC's PKU drug

5 weeks ago

News Briefing

Avidicure's $50M seed round; Flagship's new AI company that detects disease

Last month

News Briefing

Veraxa makes a SPAC deal; Illumina discloses layoffs

Last month

News Briefing

Danaher expects about $350M in tariff costs; Alumis, Acelyrin adjust deal terms

Last month

News Briefing

Novartis terminates knee pain study; Telix reports brain tumor data

Last month

News Briefing

about the author

author articles

GLP-1s may cut cancer risk; Gyre’s stock falls after hep B data and offering

Moderna pulls application for Covid-flu shot; Another IPO in Hong Kong

SV Health’s $269M dementia fund; Schrödinger lays off 7% of staff

Ionis details late-stage data for heart drug; Armata’s promising staph infection therapy

FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval

Enliven stops work on solid tumor drug; Pulmatrix to divest assets

SK, Carlyle bolster bluebird bio bid; Therini Bio raises $39M

Axsome's $570M loan with Blackstone; Altimmune makes its own credit deal

FDA clears in vivo blood stem cell editing trial; Abeona's $155M PRV sale

AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China

ALX Oncology won’t seek approval for CD47 drug in gastric cancer; Korro Bio’s layoffs

European regulators to review Valneva shot; Jazz's stock dips on subpar first-quarter revenue

Lilly to pay up to $415M in ALS deal; Actuate’s mid-stage pancreatic cancer data

Unity lays off 'all' workers; Novo to get FDA decision on oral Wegovy this year

Kura gets $45M milestone payment from Kyowa Kirin; Pliant’s restructuring

Arvinas ends plans for two Phase 3 breast cancer trials; Phathom makes cuts

Immunic’s stock falls on multiple sclerosis data; Entrada’s layoffs

AbbVie’s Rinvoq is approved in giant cell arteritis; Relmada shares bladder cancer data

Biohaven gets an up to $600M investment; Prilenia, Ferrer make a deal in Europe

Lilly asks EU regulator to revisit Kisunla; CHMP recommends PTC's PKU drug

Avidicure's $50M seed round; Flagship's new AI company that detects disease

Veraxa makes a SPAC deal; Illumina discloses layoffs

Danaher expects about $350M in tariff costs; Alumis, Acelyrin adjust deal terms

Novartis terminates knee pain study; Telix reports brain tumor data